Clinical Trials: Phase II Trial of High-Dose Bevacizumab in the Treatment of Patients With Advanced Clear Cell Renal Carcinoma

Sponsor and Collaborators
Sarah Cannon Research Institute
Genentech

Contact
John D. Hainsworth, MD
615-329-7274
jhainsworth@tnonc.com

Trials Info
615-329-7274 
trialsinfo@scresearch.net

Principal Investigator
John D. Hainsworth, MD
Sarah Cannon Research Institute

ClinicalTrials.gov Identifier
NCT00455975

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs